1st Biotherapeutics
Seongnam
About 1st Biotherapeutics
1STBIO is dedicated to developing breakthrough therapies with a key value to provide novel medicines to patients. We are focused on discovery and development of innovative first-in-class therapeutic candidates with highly likelihood of clinical success. 1STBIO currently has 24 employees with expertise in biochemistry, medicinal chemistry, pharmacology, and business development. We are working as a core expertise team of drug discovery/development and are rigorously connected to R&D networking of academia, hospitals, industry, CRO’s and investors in Korea, China and US. Our ultimate goal is to use our experience and knowledge to discover and develop effective molecular therapeutics for patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $14.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2020)
- Website: 1stbio.com
- Phone: 031) 8023-5333
Industries & Categories
Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/1st-biotherapeutics-60177 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.